Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jbs (JBS) Cash & Equivalents (2023 - 2026)

Jbs has reported Cash & Equivalents over the past 4 years, most recently at $4.6 billion for Q1 2026.

  • For Q1 2026, Cash & Equivalents fell 18.68% year-over-year to $4.6 billion; the TTM value through Mar 2026 reached $4.6 billion, down 18.68%, while the annual FY2025 figure was $4.6 billion, 18.68% down from the prior year.
  • Cash & Equivalents for Q1 2026 was $4.6 billion at Jbs, roughly flat from $4.6 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $5.6 billion in Q4 2024 and troughed at $4.6 billion in Q4 2025.
  • A 4-year average of $5.0 billion and a median of $4.6 billion in 2023 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: grew 22.85% in 2024 and later dropped 18.68% in 2025.
  • Year by year, Cash & Equivalents stood at $4.6 billion in 2023, then increased by 22.85% to $5.6 billion in 2024, then dropped by 18.68% to $4.6 billion in 2025, then changed by 0.0% to $4.6 billion in 2026.
  • Business Quant data shows Cash & Equivalents for JBS at $4.6 billion in Q1 2026, $4.6 billion in Q4 2025, and $5.6 billion in Q1 2025.